JP2021532742A5 - - Google Patents
Info
- Publication number
- JP2021532742A5 JP2021532742A5 JP2021504286A JP2021504286A JP2021532742A5 JP 2021532742 A5 JP2021532742 A5 JP 2021532742A5 JP 2021504286 A JP2021504286 A JP 2021504286A JP 2021504286 A JP2021504286 A JP 2021504286A JP 2021532742 A5 JP2021532742 A5 JP 2021532742A5
- Authority
- JP
- Japan
- Prior art keywords
- nef
- domain
- tcr
- cells
- amino acid
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2018097235 | 2018-07-26 | ||
| CNPCT/CN2018/097235 | 2018-07-26 | ||
| PCT/CN2019/097969 WO2020020359A1 (en) | 2018-07-26 | 2019-07-26 | Nef-containing t cells and methods of producing thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021532742A JP2021532742A (ja) | 2021-12-02 |
| JP2021532742A5 true JP2021532742A5 (https=) | 2022-07-06 |
| JPWO2020020359A5 JPWO2020020359A5 (https=) | 2022-07-06 |
Family
ID=69181353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021504286A Pending JP2021532742A (ja) | 2018-07-26 | 2019-07-26 | Ｎｅｆを含むｔ細胞及びその生成方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220177524A1 (https=) |
| EP (1) | EP3827075A4 (https=) |
| JP (1) | JP2021532742A (https=) |
| KR (1) | KR20210049806A (https=) |
| CN (2) | CN112771154B (https=) |
| AU (1) | AU2019312411A1 (https=) |
| CA (1) | CA3103337A1 (https=) |
| IL (1) | IL280240A (https=) |
| MX (1) | MX2021000934A (https=) |
| SG (1) | SG11202012253WA (https=) |
| TW (1) | TW202020146A (https=) |
| WO (1) | WO2020020359A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9273283B2 (en) * | 2009-10-29 | 2016-03-01 | The Trustees Of Dartmouth College | Method of producing T cell receptor-deficient T cells expressing a chimeric receptor |
| WO2021180665A1 (en) * | 2020-03-09 | 2021-09-16 | Janssen Pharmaceutica Nv | Compositions and methods for quantifying integration of recombinant vector nucleic acid |
| WO2022116086A1 (en) * | 2020-12-03 | 2022-06-09 | Janssen Biotech, Inc. | Bcma-targeted car-t cell therapy for multiple myeloma |
| IL304904A (en) * | 2021-02-01 | 2023-10-01 | St Phi Therapeutics Co Ltd | Target protein degradation system and its use |
| WO2022198027A1 (en) * | 2021-03-18 | 2022-09-22 | The Wistar Institute Of Anatomy And Biology | DNA-ENCODED BISPECIFIC ANTIBODIES TARGETING IL13Rα2 AND METHODS OF USE IN CANCER THERAPEUTICS |
| EP4378952A4 (en) * | 2021-07-30 | 2025-09-24 | St Phi Therapeutics Co Ltd | UNIVERSAL T LYMPHOCYTE AND ITS USE |
| WO2023077343A1 (en) * | 2021-11-04 | 2023-05-11 | Janssen Biotech, Inc. | Bcma-targeted car-t cell therapy for multiple myeloma |
| WO2023081752A1 (en) * | 2021-11-04 | 2023-05-11 | Janssen Biotech, Inc. | Bcma-targeted car-t cell therapy for multiple myeloma |
| EP4561628A1 (en) * | 2022-07-29 | 2025-06-04 | Legend Biotech Ireland Limited | Methods for promoting persistence of cell therapy |
| EP4612168A1 (en) * | 2022-11-04 | 2025-09-10 | Wugen, Inc. | Generation of cd3 expressing immune cells for use in conjunction with cd3 binding bispecific targeting agents |
| WO2024153211A1 (en) * | 2023-01-19 | 2024-07-25 | Nanjing Legend Biotech Co., Ltd. | Fusion polypeptides for targeted protein degradation and mehtods of use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2292772A1 (en) * | 2001-07-05 | 2011-03-09 | Novartis Vaccines and Diagnostics, Inc. | HIV vaccination with a DNA encoding a HIV polypeptide and a HIV polypeptide |
| CN101027084B (zh) * | 2004-08-17 | 2012-02-22 | 古斯达威罗斯研究所 | 用于调节免疫的突变型hiv nef |
| US9273283B2 (en) * | 2009-10-29 | 2016-03-01 | The Trustees Of Dartmouth College | Method of producing T cell receptor-deficient T cells expressing a chimeric receptor |
| KR102437522B1 (ko) * | 2012-05-25 | 2022-08-26 | 셀렉티스 | 면역요법을 위한 동종이형 및 면역억제제 저항성인 ｔ 세포의 조작 방법 |
| CN106459990B (zh) * | 2014-02-07 | 2021-06-01 | 麦克马斯特大学 | 三功能t细胞抗原偶联物及其制备方法和用途 |
| LT3134432T (lt) * | 2014-04-25 | 2020-04-10 | Bluebird Bio, Inc. | Mnd promotorius chimerinių antigenų receptoriams |
| EA201891641A1 (ru) * | 2016-01-21 | 2019-01-31 | Пфайзер Инк. | Химерные антигенные рецепторы, нацеленные на вариант iii рецептора эпидермального фактора роста |
| CN109415687A (zh) * | 2016-04-07 | 2019-03-01 | 蓝鸟生物公司 | 嵌合抗原受体t细胞组合物 |
| EP3512950A1 (en) * | 2016-09-14 | 2019-07-24 | Benitec Biopharma Limited | REAGENTS FOR PRODUCING T-CELLS WITH NON-FUNCTIONAL T-CELL RECEPTORS (TCRs) COMPOSITIONS COMPRISING SAME AND USE THEREOF |
| CN110520524A (zh) * | 2017-04-14 | 2019-11-29 | 综合医院公司 | 靶向肿瘤微环境的嵌合抗原受体t细胞 |
| BR112019021857A2 (pt) * | 2017-04-19 | 2020-06-02 | Allogene Therapeutics, Inc. | Métodos e composições de célula t aperfeiçoada |
-
2019
- 2019-07-26 JP JP2021504286A patent/JP2021532742A/ja active Pending
- 2019-07-26 SG SG11202012253WA patent/SG11202012253WA/en unknown
- 2019-07-26 KR KR1020217005328A patent/KR20210049806A/ko not_active Withdrawn
- 2019-07-26 TW TW108126647A patent/TW202020146A/zh unknown
- 2019-07-26 EP EP19841972.3A patent/EP3827075A4/en not_active Withdrawn
- 2019-07-26 AU AU2019312411A patent/AU2019312411A1/en not_active Abandoned
- 2019-07-26 CN CN201980062656.7A patent/CN112771154B/zh active Active
- 2019-07-26 WO PCT/CN2019/097969 patent/WO2020020359A1/en not_active Ceased
- 2019-07-26 CN CN202411827547.9A patent/CN119661659A/zh not_active Withdrawn
- 2019-07-26 US US17/262,787 patent/US20220177524A1/en not_active Abandoned
- 2019-07-26 CA CA3103337A patent/CA3103337A1/en active Pending
- 2019-07-26 MX MX2021000934A patent/MX2021000934A/es unknown
-
2021
- 2021-01-18 IL IL280240A patent/IL280240A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021532742A5 (https=) | ||
| US20190023764A1 (en) | Car having replicated binding motifs in a co-stimulatory domain | |
| AU2021307614B2 (en) | Engineered immune cell for allotransplantation | |
| US11180553B2 (en) | Chimeric antigen receptor | |
| AU2019288733A1 (en) | Chimeric transmembrane proteins and uses thereof | |
| JP2019525956A5 (https=) | ||
| IL293716A (en) | lilrb1-based chimeric antigen receptor | |
| JP2021514631A5 (https=) | ||
| JP7699154B2 (ja) | 腫瘍微小環境を逆転させる融合タンパク質及びその使用 | |
| JPWO2022183072A5 (https=) | ||
| CN114015656A (zh) | 用于同种异体移植的工程化免疫细胞 | |
| CN111542545A (zh) | Cd38定向嵌合抗原受体构建体 | |
| JPWO2020106843A5 (https=) | ||
| KR20230137923A (ko) | 신규한 키메라 항원 수용체 및 이의 용도 | |
| WO2018045034A1 (en) | Chimeric antigen receptors having gitr intracellular domain as co-stimulatory domain | |
| TW202432833A (zh) | 新穎ｃｄ１９結合體、包含彼之ｃａｒ—ｔ構築體及其使用方法 | |
| JPWO2022178367A5 (https=) | ||
| CN117683139A (zh) | 组成型嵌合细胞因子受体及表达其的免疫细胞及应用 | |
| JPWO2020020359A5 (https=) | ||
| JPWO2019165116A5 (https=) | ||
| TW202430565A (zh) | 包含與il18組合之新穎cd19結合體之car-t構築體及其使用方法 | |
| WO2024179620A2 (zh) | 耐免疫排斥的工程化细胞 | |
| JPWO2022182890A5 (https=) | ||
| JPWO2021211948A5 (https=) | ||
| EP4653524A1 (en) | Function-enhanced cell therapy |